Source: School Course 13



Rating:

Share or cite this content

Citations should be made in the following way:
L. Reichman (New Jersey, USA). Perspectives on the new drugs pipeline. School Course 13

Member's Comments

No comment yet.

Related content which might interest you: Facts and perspectives in the development of new anti-TB drugs Source: Annual Congress 2008 - New insights into tuberculosis control Year: 2008 Prospects for new compounds tiosemikarbazonami class to create drugs with antituberculosis activity Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014 Clinical implications and opportunities for new drug therapies Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications Year: 2008 Facts and perspectives in the development of new diagnostics Source: Annual Congress 2008 - New insights into tuberculosis control Year: 2008 Clinical use of new and repurposed drugs: the role and contribution of the ERS collaborative projects Source: International Congress 2017 – In the frontline of the fight against tuberculosis Year: 2017 Classification of antituberculosis drugs: a new proposal based on the most recent evidence Source: Eur Respir J 2015; 46: 887-893 Year: 2015 Rational use of new TB drugs in the EU Source: Annual Congress 2012 - New guidelines in respiratory infections Year: 2012 HAP/VAP : new guidelines, new approaches Source: International Congress 2018 – Chinese Programme 2018: Part II Year: 2018 Filling in the gaps- Translational research to develop new therapies  Source: International Congress 2017 – Bronchiectasis: from guidelines to real life Year: 2017 Tuberculosis elimination, patients' lives and rational use of new drugs: revisited Source: Eur Respir J 2016; 47: 664-667 Year: 2016 Human translational medicine in ILD: the promise of new drugs Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Bronchiectasis: new therapies and perspectives Source: International Congress 2018 – Bronchiectasis: new insights in diagnosis and treatment Year: 2018 Biologics: current use and future applications for personalised therapy Source: Virtual Congress 2021 – Wheezing illnesses along the life span Year: 2021 What do we need in the clinic and what approach can clinicians take to improve the drug development pipeline? Source: ERS Research Seminar 2016 Year: 2016 Therapeutic management - Current status and future developments Source: COVID-19 Videos Year: 2020